首页> 美国卫生研究院文献>Protein Science : A Publication of the Protein Society >Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins
【2h】

Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins

机译:束缚的RAMP降钙素受体样受体胞外域融合蛋白选择性结合CGRP和肾上腺髓质素肽

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Calcitonin gene-related peptide (CGRP) and adrenomedullin (AM) are related peptides that are potent vasodilators. The CGRP and AM receptors are heteromeric protein complexes comprised of a shared calcitonin receptor-like receptor (CLR) subunit and a variable receptor activity modifying protein (RAMP) subunit. RAMP1 enables CGRP binding whereas RAMP2 confers AM specificity. How RAMPs determine peptide selectivity is unclear and the receptor stoichiometries are a topic of debate with evidence for 1:1, 2:2, and 2:1 CLR:RAMP stoichiometries. Here, we describe bacterial production of recombinant tethered RAMP-CLR extracellular domain (ECD) fusion proteins and biochemical characterization of their peptide binding properties. Tethering the two ECDs ensures complex stability and enforces defined stoichiometry. The RAMP1-CLR ECD fusion purified as a monomer, whereas the RAMP2-CLR ECD fusion purified as a dimer. Both proteins selectively bound their respective peptides with affinities in the low micromolar range. Truncated CGRP(27-37) and AM(37-52) fragments were identified as the minimal ECD complex binding regions. The CGRP C-terminal amide group contributed to, but was not required for, ECD binding, whereas the AM C-terminal amide group was essential for ECD binding. Alanine-scan experiments identified CGRP residues T30, V32, and F37 and AM residues P43, K46, I47, and Y52 as critical for ECD binding. Our results identify CGRP and AM determinants for receptor ECD complex binding and suggest that the CGRP receptor functions as a 1:1 heterodimer. In contrast, the AM receptor may function as a 2:2 dimer of heterodimers, although our results cannot rule out 2:1 or 1:1 stoichiometries.
机译:降钙素基因相关肽(CGRP)和肾上腺髓质素(AM)是有效的血管扩张剂的相关肽。 CGRP和AM受体是异源蛋白复合物,由共享的降钙素受体样受体(CLR)亚基和可变受体活性修饰蛋白(RAMP)亚基组成。 RAMP1启用CGRP绑定,而RAMP2赋予AM特异性。目前尚不清楚RA​​MP如何确定肽的选择性,受体化学计量是一个有争议的话题,其中有1:1、2:2和2:1 CLR:RAMP化学计量的证据。在这里,我们描述了重组束缚的RAMP-CLR细胞外域(ECD)融合蛋白的细菌生产及其肽结合特性的生化特性。拴系两个ECD可确保复杂的稳定性并强制执行规定的化学计量。 RAMP1-CLR ECD融合纯化为单体,而RAMP2-CLR ECD融合纯化为二聚体。两种蛋白都以低微摩尔范围的亲和力选择性结合各自的肽。截短的CGRP(27-37)和AM(37-52)片段被确定为最小ECD复合物结合区域。 CGRP C末端酰胺基有助于但不要求ECD结合,而AM C末端酰胺基对于ECD结合必不可少。丙氨酸扫描实验确定CGRP残基T30,V32和F37和AM残基P43,K46,I47和Y52对ECD结合至关重要。我们的研究结果确定了受体ECD复合物结合的CGRP和AM决定因素,并表明CGRP受体以1:1异二聚体的形式起作用。相反,尽管我们的结果不能排除2:1或1:1的化学计量,但AM受体可能是异二聚​​体的2:2二聚体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号